Electric Therapy Traction Table Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 112 |
The global Hypertension RDN Therapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
r-Renal Denervation(rRDN) Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Hypertension RDN Therapy include Medtronic, ReCor Medical, Sonivies, Covidien, Boston Scientific, Johnson & Johnson, Terumo Corporation, Angiocare and Shanghai Golden Leaf Med Tec, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
Renal denervation (also called renal ablation) is a minimally invasive, investigational procedure to treat hypertension (high blood pressure) that hasn't improved with other treatments. This type of hypertension is called resistant hypertension
This report aims to provide a comprehensive presentation of the global market for Hypertension RDN Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hypertension RDN Therapy. This report contains market size and forecasts of Hypertension RDN Therapy in global, including the following market information:
Global Hypertension RDN Therapy Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hypertension RDN Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hypertension RDN Therapy Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Hypertension RDN Therapy Market Segment Percentages, by Type, 2022 (%)
r-Renal Denervation(rRDN)
u-Renal Denervation(uRDN)
Global Hypertension RDN Therapy Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Hypertension RDN Therapy Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Others
Global Hypertension RDN Therapy Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Hypertension RDN Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hypertension RDN Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Hypertension RDN Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Medtronic
ReCor Medical
Sonivies
Covidien
Boston Scientific
Johnson & Johnson
Terumo Corporation
Angiocare
Shanghai Golden Leaf Med Tec
Shanghai Bio-Heart Biological Technology
Xinmai Medical Equipment
Microport Ep Medtech
Cryofocus Medtech
Outline of Major Chapters:
Chapter 1: Introduces the definition of Hypertension RDN Therapy, market overview.
Chapter 2: Global Hypertension RDN Therapy market size in revenue.
Chapter 3: Detailed analysis of Hypertension RDN Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Hypertension RDN Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Hypertension RDN Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hypertension RDN Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hypertension RDN Therapy Overall Market Size
2.1 Global Hypertension RDN Therapy Market Size: 2022 VS 2029
2.2 Global Hypertension RDN Therapy Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Hypertension RDN Therapy Players in Global Market
3.2 Top Global Hypertension RDN Therapy Companies Ranked by Revenue
3.3 Global Hypertension RDN Therapy Revenue by Companies
3.4 Top 3 and Top 5 Hypertension RDN Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Hypertension RDN Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Hypertension RDN Therapy Players in Global Market
3.6.1 List of Global Tier 1 Hypertension RDN Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Hypertension RDN Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Hypertension RDN Therapy Market Size Markets, 2022 & 2029
4.1.2 r-Renal Denervation(rRDN)
4.1.3 u-Renal Denervation(uRDN)
4.2 By Type - Global Hypertension RDN Therapy Revenue & Forecasts
4.2.1 By Type - Global Hypertension RDN Therapy Revenue, 2018-2023
4.2.2 By Type - Global Hypertension RDN Therapy Revenue, 2024-2029
4.2.3 By Type - Global Hypertension RDN Therapy Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Hypertension RDN Therapy Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Hypertension RDN Therapy Revenue & Forecasts
5.2.1 By Application - Global Hypertension RDN Therapy Revenue, 2018-2023
5.2.2 By Application - Global Hypertension RDN Therapy Revenue, 2024-2029
5.2.3 By Application - Global Hypertension RDN Therapy Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Hypertension RDN Therapy Market Size, 2022 & 2029
6.2 By Region - Global Hypertension RDN Therapy Revenue & Forecasts
6.2.1 By Region - Global Hypertension RDN Therapy Revenue, 2018-2023
6.2.2 By Region - Global Hypertension RDN Therapy Revenue, 2024-2029
6.2.3 By Region - Global Hypertension RDN Therapy Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Hypertension RDN Therapy Revenue, 2018-2029
6.3.2 US Hypertension RDN Therapy Market Size, 2018-2029
6.3.3 Canada Hypertension RDN Therapy Market Size, 2018-2029
6.3.4 Mexico Hypertension RDN Therapy Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Hypertension RDN Therapy Revenue, 2018-2029
6.4.2 Germany Hypertension RDN Therapy Market Size, 2018-2029
6.4.3 France Hypertension RDN Therapy Market Size, 2018-2029
6.4.4 U.K. Hypertension RDN Therapy Market Size, 2018-2029
6.4.5 Italy Hypertension RDN Therapy Market Size, 2018-2029
6.4.6 Russia Hypertension RDN Therapy Market Size, 2018-2029
6.4.7 Nordic Countries Hypertension RDN Therapy Market Size, 2018-2029
6.4.8 Benelux Hypertension RDN Therapy Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Hypertension RDN Therapy Revenue, 2018-2029
6.5.2 China Hypertension RDN Therapy Market Size, 2018-2029
6.5.3 Japan Hypertension RDN Therapy Market Size, 2018-2029
6.5.4 South Korea Hypertension RDN Therapy Market Size, 2018-2029
6.5.5 Southeast Asia Hypertension RDN Therapy Market Size, 2018-2029
6.5.6 India Hypertension RDN Therapy Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Hypertension RDN Therapy Revenue, 2018-2029
6.6.2 Brazil Hypertension RDN Therapy Market Size, 2018-2029
6.6.3 Argentina Hypertension RDN Therapy Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Hypertension RDN Therapy Revenue, 2018-2029
6.7.2 Turkey Hypertension RDN Therapy Market Size, 2018-2029
6.7.3 Israel Hypertension RDN Therapy Market Size, 2018-2029
6.7.4 Saudi Arabia Hypertension RDN Therapy Market Size, 2018-2029
6.7.5 UAE Hypertension RDN Therapy Market Size, 2018-2029
7 Hypertension RDN Therapy Companies Profiles
7.1 Medtronic
7.1.1 Medtronic Company Summary
7.1.2 Medtronic Business Overview
7.1.3 Medtronic Hypertension RDN Therapy Major Product Offerings
7.1.4 Medtronic Hypertension RDN Therapy Revenue in Global Market (2018-2023)
7.1.5 Medtronic Key News & Latest Developments
7.2 ReCor Medical
7.2.1 ReCor Medical Company Summary
7.2.2 ReCor Medical Business Overview
7.2.3 ReCor Medical Hypertension RDN Therapy Major Product Offerings
7.2.4 ReCor Medical Hypertension RDN Therapy Revenue in Global Market (2018-2023)
7.2.5 ReCor Medical Key News & Latest Developments
7.3 Sonivies
7.3.1 Sonivies Company Summary
7.3.2 Sonivies Business Overview
7.3.3 Sonivies Hypertension RDN Therapy Major Product Offerings
7.3.4 Sonivies Hypertension RDN Therapy Revenue in Global Market (2018-2023)
7.3.5 Sonivies Key News & Latest Developments
7.4 Covidien
7.4.1 Covidien Company Summary
7.4.2 Covidien Business Overview
7.4.3 Covidien Hypertension RDN Therapy Major Product Offerings
7.4.4 Covidien Hypertension RDN Therapy Revenue in Global Market (2018-2023)
7.4.5 Covidien Key News & Latest Developments
7.5 Boston Scientific
7.5.1 Boston Scientific Company Summary
7.5.2 Boston Scientific Business Overview
7.5.3 Boston Scientific Hypertension RDN Therapy Major Product Offerings
7.5.4 Boston Scientific Hypertension RDN Therapy Revenue in Global Market (2018-2023)
7.5.5 Boston Scientific Key News & Latest Developments
7.6 Johnson & Johnson
7.6.1 Johnson & Johnson Company Summary
7.6.2 Johnson & Johnson Business Overview
7.6.3 Johnson & Johnson Hypertension RDN Therapy Major Product Offerings
7.6.4 Johnson & Johnson Hypertension RDN Therapy Revenue in Global Market (2018-2023)
7.6.5 Johnson & Johnson Key News & Latest Developments
7.7 Terumo Corporation
7.7.1 Terumo Corporation Company Summary
7.7.2 Terumo Corporation Business Overview
7.7.3 Terumo Corporation Hypertension RDN Therapy Major Product Offerings
7.7.4 Terumo Corporation Hypertension RDN Therapy Revenue in Global Market (2018-2023)
7.7.5 Terumo Corporation Key News & Latest Developments
7.8 Angiocare
7.8.1 Angiocare Company Summary
7.8.2 Angiocare Business Overview
7.8.3 Angiocare Hypertension RDN Therapy Major Product Offerings
7.8.4 Angiocare Hypertension RDN Therapy Revenue in Global Market (2018-2023)
7.8.5 Angiocare Key News & Latest Developments
7.9 Shanghai Golden Leaf Med Tec
7.9.1 Shanghai Golden Leaf Med Tec Company Summary
7.9.2 Shanghai Golden Leaf Med Tec Business Overview
7.9.3 Shanghai Golden Leaf Med Tec Hypertension RDN Therapy Major Product Offerings
7.9.4 Shanghai Golden Leaf Med Tec Hypertension RDN Therapy Revenue in Global Market (2018-2023)
7.9.5 Shanghai Golden Leaf Med Tec Key News & Latest Developments
7.10 Shanghai Bio-Heart Biological Technology
7.10.1 Shanghai Bio-Heart Biological Technology Company Summary
7.10.2 Shanghai Bio-Heart Biological Technology Business Overview
7.10.3 Shanghai Bio-Heart Biological Technology Hypertension RDN Therapy Major Product Offerings
7.10.4 Shanghai Bio-Heart Biological Technology Hypertension RDN Therapy Revenue in Global Market (2018-2023)
7.10.5 Shanghai Bio-Heart Biological Technology Key News & Latest Developments
7.11 Xinmai Medical Equipment
7.11.1 Xinmai Medical Equipment Company Summary
7.11.2 Xinmai Medical Equipment Business Overview
7.11.3 Xinmai Medical Equipment Hypertension RDN Therapy Major Product Offerings
7.11.4 Xinmai Medical Equipment Hypertension RDN Therapy Revenue in Global Market (2018-2023)
7.11.5 Xinmai Medical Equipment Key News & Latest Developments
7.12 Microport Ep Medtech
7.12.1 Microport Ep Medtech Company Summary
7.12.2 Microport Ep Medtech Business Overview
7.12.3 Microport Ep Medtech Hypertension RDN Therapy Major Product Offerings
7.12.4 Microport Ep Medtech Hypertension RDN Therapy Revenue in Global Market (2018-2023)
7.12.5 Microport Ep Medtech Key News & Latest Developments
7.13 Cryofocus Medtech
7.13.1 Cryofocus Medtech Company Summary
7.13.2 Cryofocus Medtech Business Overview
7.13.3 Cryofocus Medtech Hypertension RDN Therapy Major Product Offerings
7.13.4 Cryofocus Medtech Hypertension RDN Therapy Revenue in Global Market (2018-2023)
7.13.5 Cryofocus Medtech Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LED Light-Up Blanket Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 116 |
Pelvic Floor Functional Magnetic Stimulator Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 115 |
Multi-Modality Biofeedback System Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 112 |
High Frequency Evaluation and Therapy Device Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 115 |
Choose License Type
Why Choose Us ?
24/7 Research support
Quality assurance
Information security
The report efficiently evaluates the market from various dimensions to deliver an
end-product that is informative, elaborate, and accurate and includes detailed
market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast.
The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of
xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the
industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by Types, Applications, Technology, End-use Industries, and Regions.
The report presents the current market size, and market forecast, market
opportunities, key drivers and restraints, regulatory scenario, industry trend, PESTLE
analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing
initiatives, pricing analysis, competitive landscape which help businesses in
decision making. The analysis data is based on current and historical market trends
which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any
organization to gain insight into specific business sector, aligned with specific area
of interest. Thus, SMI offers more accurate, pragmatic, and actionable information
specifically tailored to suit your business needs.
